Synthetic psilocybin(Ceruvia Lifesciences)

N/A

Report date: 2024/12/02 10:41:36

Base Information

Drug NameSynthetic psilocybin(Ceruvia Lifesciences)
Drug Alias NameSYNP-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsObsessive-Compulsive DisorderAlcoholismHeadache Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCeruvia Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesCeruvia Lifesciences
Inactive CompaniesN/A
Active IndicationsObsessive-Compulsive DisorderAlcoholismHeadache Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A